|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Acebutolol]] |
| {{Acebutolol}}
| |
| {{CMG}}; {{AE}}
| |
| | |
| '''''For patient information about Acebutolol, click [[Acebutolol (patient information)|here]]'''''
| |
| | |
| {{SB}} SECTRAL<sup>®</sup>
| |
| | |
| ==Overview==
| |
| Sectral (acebutolol HCl) is a selective, hydrophilic beta-adrenoreceptor blocking agent with mild intrinsic sympathomimetic activity for use in treating patients with hypertension and ventricular arrhythmias
| |
| | |
| ==Category==
| |
| Cardiovascular Drugs：Beta blockers
| |
| | |
| ==FDA Package Insert==
| |
| | |
| '''| [[Acebutolol indications and usage|Indications and Usage]]'''
| |
| '''| [[Acebutolol dosage and administration|Dosage and Administration]]'''
| |
| '''| [[Acebutolol dosage forms and strengths|Dosage Forms and Strengths]]'''
| |
| '''| [[Acebutolol contraindications|Contraindications]]'''
| |
| '''| [[Acebutolol warnings and precautions|Warnings and Precautions]]'''
| |
| '''| [[Acebutolol adverse reactions|Adverse Reactions]]'''
| |
| '''| [[Acebutolol drug interactions|Drug Interactions]]'''
| |
| '''| [[Acebutolol use in specific populations|Use in Specific Populations]]'''
| |
| '''| [[Acebutolol overdosage|Overdosage]]'''
| |
| '''| [[Acebutolol description|Description]]'''
| |
| '''| [[Acebutolol clinical pharmacology|Clinical Pharmacology]]'''
| |
| '''| [[Acebutolol nonclinical toxicology|Nonclinical Toxicology]]'''
| |
| '''| [[Acebutolol how supplied storage and handling|How Supplied/Storage and Handling]]'''
| |
| '''| [[Acebutolol patient counseling information|Patient Counseling Information]]'''
| |
| '''| [[Acebutolol labels and packages|Labels and Packages]]'''
| |
| | |
| ==Mechanism of Action==
| |
| The mechanism of action has not been definitively established. Possible factors that may be involved include: (1) decreased heart rate, (2) decreased myocardial contractility, (3) diminution of tonic sympathetic outflow to the periphery from cerebral vasomotor centers, (4) suppression of renin activity and (5) vasodilation and decreased peripheral vascular resistance.
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| {{beta blockers}}
| |
| | |
| [[Category:Beta blockers]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |